JD Supra

Compounding and GLP-1s: What To Expect When GLP-1 Drugs Are Removed From FDA’s Drug Shortage List

Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...
Becker's ASC

3 Key Items to Use to Evaluate the Quality of Your Sterile Injectable Compounding Pharmacy

– What are the resumes of top management? Are pharmacists leading the company? – Who is available for technical questions and how fast are they answered? – What are the qualifications of the staff and ...
JD Supra

FDA Announces End to Semaglutide Shortage, Impacting Compounders and Telehealth Providers Offering Injectable GLP-1 Drugs

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a popular glucagon-like peptide 1 (GLP-1) weight loss and diabetes ...
Morningstar

Quva Awarded National Outsourced Compounded Preparations Agreement with Premier, Inc.

SUGAR LAND, Texas, Jan. 6, 2026 /PRNewswire/ -- QuVa Pharma, Inc (Quva), a national, industry-leading provider of outsourced sterile injectable compounding services and health-system pharmacy data and ...